Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetic Macular Edema (DME)”

250 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 250 results

Early research (Phase 1)UnknownNCT04151407
What this trial is testing

The Study of Drug 601 in Patients With Diabetic Macular Edema (DME)

Who this might be right for
Diabetic Macular Edema
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 50
Testing effectiveness (Phase 2)Study completedNCT01571232
What this trial is testing

Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema

Who this might be right for
Diabetic Macular EdemaNon-proliferative Diabetic RetinopathyProliferative Diabetic Retinopathy
Retina Macula Institute 20
Early research (Phase 1)Study completedNCT01997164
What this trial is testing

Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular ("Wet") Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME)

Who this might be right for
Neovascular Age-Related Macular DegenerationDiabetic Macular Edema
Regeneron Pharmaceuticals 20
Post-approval studies (Phase 4)Study completedNCT02581995
What this trial is testing

Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME.

Who this might be right for
Macular Edema
Bayer 560
Post-approval studies (Phase 4)Study completedNCT06591598
What this trial is testing

Learn About the Blood Levels of Aflibercept When High-dose Aflibercept is Injected in Both Eyes of Participants With Diabetic Macular Edema or Neovascular Age-related Macular Degeneration

Who this might be right for
Diabetic Macular EdemaNeovascular Age-related Macular Degeneration
Bayer 51
Not applicableStudy completedNCT03889444
What this trial is testing

Chart Review: Drug Utilization Study in Participants Who Received Ozurdex™ (Dexamethasone Intravitreal Implant) 0.7 mg Injections for Visual Impairment Due to Diabetic Macular Edema (DME)

Who this might be right for
Diabetic Macular Edema
Allergan 141
Early research (Phase 1)Ended earlyNCT03790852
What this trial is testing

Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With wAMD, DME and RVO

Who this might be right for
Wet Age-related Macular DegenerationRetinal Vein OcclusionDiabetic Macular Edema
Kodiak Sciences Inc 121
Not applicableStudy completedNCT01638858
What this trial is testing

Treatment of Diabetic Macular Edema With 0.5mg Intraocular Ranibizumab (Lucentis)

Who this might be right for
Age-Related Macular Degeneration
University of Luebeck 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07457632
What this trial is testing

Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Combining Tauroursodeoxycholate and Traditional Chinese Medicine.

Who this might be right for
Diabetic Macular Edema (DME)
University of Alabama at Birmingham 69
Testing effectiveness (Phase 2)Study completedNCT05919693
What this trial is testing

A 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal (IVT) EYE103 in Patients With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (NVAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (NVAMD)Diabetic Macular Edema (DME)
EyeBiotech Ltd. 33
Testing effectiveness (Phase 2)Study completedNCT00536692
What this trial is testing

Topical Ocular Mecamylamine in Diabetic Macular Edema (DME)

Who this might be right for
Diabetic Macular Edema
CoMentis
Large-scale testing (Phase 3)Active Not RecruitingNCT06571045
What this trial is testing

Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME

Who this might be right for
Diabetic Macular Edema (DME)
EyeBiotech Ltd. 984
Early research (Phase 1)Study completedNCT02193113
What this trial is testing

A Phase I Single Ascending Dose Study of the Intravitreal Plasma Kallikrein Inhibitor KVD001 in Subjects With DME

Who this might be right for
Diabetic Macular Edema
KalVista Pharmaceuticals, Ltd. 14
Very early researchNot Yet RecruitingNCT06879301
What this trial is testing

Effectiveness of Intravitreal Injection of Aflibercept 8 mg in Resistant Diabetic Macular Edema, Retinal Vein Occlusion and Myopic Choroidal Neovascularisation Patients

Who this might be right for
Diabetic Macular Edema (DME)Retinal Vein Occlusion (RVO)Myopic Choroidal Neovascularisation
Tanta University 60
Not applicableStudy completedNCT07514559
What this trial is testing

Comparison of Intravitreal Anti-VEGF Treatment Burden in Different Retinal Diseases

Who this might be right for
Age Related Macular Degeneration (ARMD)Retinal Vein Occlusion (RVO)Diabetic Macular Edema (DME)
Hospital Hietzing 393
Large-scale testing (Phase 3)Active Not RecruitingNCT06957080
What this trial is testing

2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME

Who this might be right for
Diabetic Macular Edema (DME)
EyeBiotech Ltd. 1,054
Testing effectiveness (Phase 2)Study completedNCT02302079
What this trial is testing

Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)

Who this might be right for
Diabetes MellitusDiabetic Macular Edema
Astellas Pharma Europe B.V. 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT06116916
What this trial is testing

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema (DME)
Kyowa Kirin Co., Ltd. 150
Not applicableEnded earlyNCT01788475
What this trial is testing

Safety and Effectiveness of Ozurdex Steroid Implants for DME After Vitrectomy Surgery

Who this might be right for
Diabetic Macular Edema
Lahey Clinic 3
Post-approval studies (Phase 4)WithdrawnNCT03059277
What this trial is testing

Intravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal Ranibizumab

Who this might be right for
Diabetic Macular Edema
Southeast Clinical Research Associates, LLC
Load More Results